Mimedx (MDXG) Change in Accured Expenses (2011 - 2026)

Mimedx has disclosed Change in Accured Expenses across 16 years of filings, most recently posting $250000.0 for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $250000.0, up 442.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 17.08% YoY), and the FY2025 annual result was $2.4 million, down 18.13% from the prior year.
• Change in Accured Expenses came in at $250000.0 for Q1 2026 at Mimedx, down from $3.5 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $8.0 million in Q3 2022 to a low of -$6.9 million in Q2 2022.
• The 5-year median for Change in Accured Expenses is $522000.0 (2024), against an average of $434470.6.
• Across the five-year window, Change in Accured Expenses slumped 470.84% in 2023 and surged 1472.49% in 2025, its largest moves.
• Mimedx's Change in Accured Expenses stood at $655000.0 in 2022, then plunged by 470.84% to -$2.4 million in 2023, then jumped by 257.55% to $3.8 million in 2024, then slipped by 7.29% to $3.5 million in 2025, then slumped by 92.95% to $250000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $250000.0 (Q1 2026), $3.5 million (Q4 2025), and -$4.7 million (Q3 2025), per Business Quant data.